These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 25667190)

  • 21. Suppressing phosphoinositide-specific phospholipases Cγ1 promotes mineralization of osteoarthritic subchondral bone osteoblasts via increasing autophagy, thereby ameliorating articular cartilage degeneration.
    Wang Y; Zhang T; Xu Y; Chen R; Qu N; Zhang B; Xia C
    Bone; 2022 Jan; 154():116262. PubMed ID: 34813965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone morphogenetic protein-2-induced Wnt/β-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes.
    Papathanasiou I; Malizos KN; Tsezou A
    Arthritis Res Ther; 2012 Apr; 14(2):R82. PubMed ID: 22513174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts.
    Hilal G; Massicotte F; Martel-Pelletier J; Fernandes JC; Pelletier JP; Lajeunesse D
    J Bone Miner Res; 2001 Apr; 16(4):713-21. PubMed ID: 11315999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells.
    Suzuki A; Ghayor C; Guicheux J; Magne D; Quillard S; Kakita A; Ono Y; Miura Y; Oiso Y; Itoh M; Caverzasio J
    J Bone Miner Res; 2006 May; 21(5):674-83. PubMed ID: 16734382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte growth factor-induced BMP-2 expression is mediated by c-Met receptor, FAK, JNK, Runx2, and p300 pathways in human osteoblasts.
    Tsai SY; Huang YL; Yang WH; Tang CH
    Int Immunopharmacol; 2012 Jun; 13(2):156-62. PubMed ID: 22504529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2.
    Lecanda F; Avioli LV; Cheng SL
    J Cell Biochem; 1997 Dec; 67(3):386-96. PubMed ID: 9361193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein.
    Maxis K; Delalandre A; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
    Arthritis Res Ther; 2006; 8(6):R181. PubMed ID: 17156456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
    Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gremlin-1 and BMP-4 Overexpressed in Osteoarthritis Drive an Osteochondral-Remodeling Program in Osteoblasts and Hypertrophic Chondrocytes.
    Pérez-Lozano ML; Sudre L; van Eegher S; Citadelle D; Pigenet A; Lafage-Proust MH; Pastoureau P; De Ceuninck F; Berenbaum F; Houard X
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of subchondral bone osteoblast metabolism by cyclic compression.
    Sanchez C; Pesesse L; Gabay O; Delcour JP; Msika P; Baudouin C; Henrotin YE
    Arthritis Rheum; 2012 Apr; 64(4):1193-203. PubMed ID: 22034083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
    Tat SK; Pelletier JP; Mineau F; Caron J; Martel-Pelletier J
    Bone; 2011 Sep; 49(3):559-67. PubMed ID: 21700005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of soluble 14-3-3∊ as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis.
    Priam S; Bougault C; Houard X; Gosset M; Salvat C; Berenbaum F; Jacques C
    Arthritis Rheum; 2013 Jul; 65(7):1831-42. PubMed ID: 23552998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter.
    Papathanasiou I; Kostopoulou F; Malizos KN; Tsezou A
    Arthritis Res Ther; 2015 Jun; 17(1):160. PubMed ID: 26071314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts.
    Sanchez C; Deberg MA; Piccardi N; Msika P; Reginster JY; Henrotin YE
    Osteoarthritis Cartilage; 2005 Nov; 13(11):979-87. PubMed ID: 16243232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone morphogenetic protein-2 modulates Wnt and frizzled expression and enhances the canonical pathway of Wnt signaling in normal keratinocytes.
    Yang L; Yamasaki K; Shirakata Y; Dai X; Tokumaru S; Yahata Y; Tohyama M; Hanakawa Y; Sayama K; Hashimoto K
    J Dermatol Sci; 2006 May; 42(2):111-9. PubMed ID: 16442268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes.
    Henrotin YE; Deberg MA; Crielaard JM; Piccardi N; Msika P; Sanchez C
    J Rheumatol; 2006 Aug; 33(8):1668-78. PubMed ID: 16832844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo.
    Chikazu D; Li X; Kawaguchi H; Sakuma Y; Voznesensky OS; Adams DJ; Xu M; Hoshio K; Katavic V; Herschman HR; Raisz LG; Pilbeam CC
    J Bone Miner Res; 2002 Aug; 17(8):1430-40. PubMed ID: 12162497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.
    Tanaka K; Inoue Y; Hendy GN; Canaff L; Katagiri T; Kitazawa R; Komori T; Sugimoto T; Seino S; Kaji H
    Bone; 2012 Jul; 51(1):158-67. PubMed ID: 22579779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relaxin augments BMP-2-induced osteoblast differentiation and bone formation.
    Moon JS; Kim SH; Oh SH; Jeong YW; Kang JH; Park JC; Son HJ; Bae S; Park BI; Kim MS; Koh JT; Ko HM
    J Bone Miner Res; 2014 Jul; 29(7):1586-96. PubMed ID: 24643989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade.
    Reboul P; Pelletier JP; Tardif G; Benderdour M; Ranger P; Bottaro DP; Martel-Pelletier J
    Arthritis Rheum; 2001 Jan; 44(1):73-84. PubMed ID: 11212179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.